Breaking News

Modernizing Biopharmaceutical Sampling

July 31, 2014

Funded so far by Pfizer and Lilly, Bend Research is beta testing the Modular Automated Sampling Technology platform, that would bring process analytical technology (PAT) to biopharmaceutical development and manufacturing

Bend Research and pharmaceutical company partners are currently beta testing MAST, a modular automated sampling technology platform designed to allow for hands-off and contamination-free sampling from up to 8 bioreactors at a time.  The platform has also been designed to enable at-line analysis, automated scheduling and other benefits.  For more information, click here. 
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks